PYPD

PolyPid Ltd.

Price

$5.16

return (12m)

49.57%

p/e

-2.93

p/bv

21.34

DIVIDEND YIELD

0.00%

PYPD price

PolyPid

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PYPD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

1.18%

3 months

8.86%

1 year

49.57%

2 years

49.13%

5 years

-97.85%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals PYPD

Valuation

P/E

-2.93

Sector -3.50

Industry -3.50

P/BV

21.34

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

-13.81

Sector -214.99

Industry -214.99

EV/EBIT

-13.81

Sector -47.59

Industry -47.59

P/EBITDA

-3.60

Sector -21.41

Industry -21.41

P/EBIT

-3.60

Sector -28.65

Industry -28.65

P/Total Assets

7.55

Sector 1.19

Industry 1.19

P/Net Current Assets

-119.76

Sector -11.97

Industry -11.97

P/Working Capital

50.36

Sector -167.95

Industry -167.95

EPS

-1.76

Sector -1.81

Industry -1.81

BVPS

0.24

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

0.00%

Sector 41.30%

Industry 41.30%

EBITDA Margin

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

0.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

0.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.00

Sector 0.02

Industry 0.02

Profitability

ROE

-728.04%

Sector -56.04%

Industry -56.04%

ROA

-257.50%

Sector -60.31%

Industry -60.31%

ROIC

-387.65%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.35

Sector 2.89

Industry 2.89

Net Debt / EBITDA

0.84

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

0.84

Sector -8.06

Industry -8.06

Net Debt / Equity

-1.22

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.35

Sector 0.46

Industry 0.46

Liabilities/Assets

0.65

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-1.64%

Sector -

Industry -

Fundamentals PYPD

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PYPD PolyPid Ltd.	$5.16	53.12%	0.00%	-2.93	21.34	-728.04%	0.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PYPD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT PolyPid

PolyPid Ltd.

Average Investor10 user rating

4.0 (0 people)

United States

18 years

Founded: 2008

2020

Time since IPO - 6 years

69

Employees

PolyPid Ltd. (United States) is listed on the Nasdaq and has a market capitalization of $114.97 million, with shareholders equity totaling $5.39 million.

The company employs approximately 69 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, PolyPid Ltd. reported $- in revenue, generating net income of $-39.23 million.

Key financial metrics include a P/E ratio of -2.93, a price-to-book (P/B) ratio of 21.34, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PYPD.

Market cap

$114.97 million

Net worth

$5.39 million

$5,388,000.00

Assets

$15.23 million

$15,234,000.00

Total Shares Outstanding

22.28 million

22,280,000

Average Daily Trading Volume

$202.05 Thousand

$202,048.68

Sector

Health Care

Industry

Biotechnology

PYPD

PYPD revenue and profits

Financial Results PYPD

DRAG THE FRAME TO SEE MORE DATA

PYPD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of PolyPid (PYPD) today?

A cotação de PolyPid (PYPD) hoje está em US$ 5.16, com uma variação de 49.57% em relação ao último ano. A cotação de PolyPid (PYPD) iniciou o ano negociando na casa dos US$ 4.34 e hoje está em US$ 5.16. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de PolyPid (PYPD) e dados de ações do Ibovespa e mercados internacionais.

Quando PolyPid (PYPD) paga dividendos?

PolyPid (PYPD) não distribuiu dividendos no último ano.

Is PolyPid (PYPD) a good investment?

Atualmente, PolyPid (PYPD) está cotada a US$ 5.16, com um P/L de -2.93, representando um desvio de -127% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 49.57 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 49.57%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy PolyPid (PYPD) stock?

Investir em ações de PolyPid (PYPD) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of PolyPid (PYPD) yield today?

A rentabilidade de PolyPid (PYPD) foi de 1.18% no último mês, 49.57% no último ano e -97.85% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de PolyPid (PYPD) hoje, o investimento total seria de US$ 516.00, com base na cotação atual de US$ 5.16.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 771.78
Em 5 anos: US$ 11.09
Em 10 anos: US$ 516.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

PYPD

PolyPid Ltd.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment PYPD

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING PYPD WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT PolyPid

PolyPid Ltd.

United States

18 years

2020

69

PROFIT X PRICE PYPD

Financial Results PYPD

PYPD cash flow

Asset, Revenue and Profit Growth - PYPD

PYPD balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions